Robert Siegel, MD

Articles

Dr. Siegel on Induction Therapy for Head and Neck Cancer

August 28th 2017

Robert Siegel, MD, chair, professor of medicine, director, Division of Hematology/Oncology, George Washington University, discusses induction therapy for head and neck cancer.

Dr. Siegel on Benefits With Transoral Surgery and Chemotherapy for Head and Neck Cancer

August 24th 2017

Robert Siegel, MD, chair, professor of medicine, director, Division of Hematology/Oncology, George Washington University, discusses the benefits of chemotherapy and transoral surgery for patients with head and neck cancer.

Dr. Siegel on Study of Induction Chemotherapy and Transoral Surgery in Oropharyngeal Cancer

August 23rd 2017

Robert Siegel, MD, chair, professor of medicine, director, Division of Hematology/Oncology, George Washington University, discusses a study of induction chemotherapy and transoral surgery in patients with oropharyngeal cancer.

Dr. Siegel on the Da Vinci Robotic Assisted Surgery Technique in Head and Neck Cancer

August 18th 2017

Robert Siegel, MD, chair, professor of medicine, director, Division of Hematology/Oncology, George Washington University, discusses the da Vinci robotic-assisted surgery technique in head and neck cancer.

Dr. Siegel on Results of Chemotherapy and Transoral Surgery Study for Head and Neck Cancer

July 11th 2017

Robert Siegel, MD, chair, professor of medicine, director, Division of Hematology/Oncology, George Washington University, discusses a phase II study investigating induction chemotherapy and transoral surgery for patients with head and neck cancer.

Dr. Siegel on the Treatment of HPV-Associated Head and Neck Cancer

July 7th 2017

Robert Siegel, MD, chair, professor of medicine, director, Division of Hematology/Oncology, George Washington University, discusses the treatment for patients with HPV-associated head and neck cancer.

Dr. Siegel Discusses RT-Related AEs for Patients With Oropharyngeal Squamous Cell Carcinomas

July 6th 2017

Robert Siegel, MD, chair, professor of medicine, director, Division of Hematology/Oncology, George Washington University, discusses the adverse events (AEs) associated with radiation therapy (RT) for patients with oropharyngeal squamous cell carcinomas.